Variant report

Variant	esv1815766
Chromosome Location	chr19:53511347-53560297
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:249)
CpG islands
(count:491)
Chromatin interactive
region (count:7)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:249 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr19:53558916-53559216	K562	blood:	n/a	n/a
2	ATF3	chr19:53558902-53559223	K562	blood:	n/a	n/a
3	BACH1	chr19:53518961-53519336	H1-hESC	embryonic stem cell:	n/a	n/a
4	BHLHE40	chr19:53558384-53558600	K562	blood:	n/a	n/a
5	BRCA1	chr19:53548078-53548353	H1-hESC	embryonic stem cell:	n/a	n/a
6	CBX3	chr19:53556503-53556768	K562	blood:	n/a	n/a
7	CEBPB	chr19:53520045-53520364	IMR90	lung:	n/a	n/a
8	CEBPB	chr19:53559033-53559111	K562	blood:	n/a	n/a
9	CEBPB	chr19:53514645-53514955	HepG2	liver:	n/a	chr19:53514790-53514801
10	CEBPB	chr19:53514683-53514869	A549	lung:	n/a	chr19:53514790-53514801
11	CEBPB	chr19:53514622-53514961	K562	blood:	n/a	chr19:53514790-53514801
12	CEBPB	chr19:53520072-53520352	H1-hESC	embryonic stem cell:	n/a	n/a
13	CEBPB	chr19:53520052-53520352	K562	blood:	n/a	n/a
14	CEBPB	chr19:53520162-53520365	MCF-7	breast:	n/a	n/a
15	CEBPB	chr19:53514709-53514946	Hela-S3	cervix:	n/a	chr19:53514790-53514801
16	CTCF	chr19:53522940-53523416	MCF-7	breast:	n/a	n/a
17	CTCF	chr19:53523070-53523239	NHEK	skin:	n/a	n/a
18	CTCF	chr19:53523053-53523226	Fibrobl	skin:	n/a	n/a
19	CTCF	chr19:53523020-53523170	HEEpiC	esophagus:	n/a	n/a
20	CTCF	chr19:53522961-53523288	T-47D	breast:	n/a	n/a
21	CTCF	chr19:53522989-53523273	K562	blood:	n/a	n/a
22	CTCF	chr19:53523155-53523191	LNCaP	prostate:	n/a	n/a
23	CTCF	chr19:53523020-53523170	HRPEpiC	eye:	n/a	n/a
24	CTCF	chr19:53523000-53523150	HEK293	kidney:	n/a	n/a
25	CTCF	chr19:53513826-53514079	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTCF	chr19:53523116-53523172	GM12878	blood:	n/a	n/a
27	CTCF	chr19:53523195-53523198	GM10266	blood:	n/a	n/a
28	CTCF	chr19:53523060-53523210	AG09309	skin:	n/a	n/a
29	CTCF	chr19:53554569-53554639	Lung_OC	lung:	n/a	n/a
30	CTCF	chr19:53523018-53523242	HepG2	liver:	n/a	n/a
31	CTCF	chr19:53523084-53523245	Hela-S3	cervix:	n/a	n/a
32	CTCF	chr19:53523080-53523230	K562	blood:	n/a	n/a
33	CTCF	chr19:53523080-53523230	BE2_C	brain:	n/a	n/a
34	CTCF	chr19:53523060-53523210	HCFaa	heart:	n/a	n/a
35	CTCF	chr19:53523100-53523250	HCPEpiC	choroid plexus:	n/a	n/a
36	CTCF	chr19:53538670-53538733	GM10248	blood:	n/a	n/a
37	CTCF	chr19:53523080-53523230	HMEC	breast:	n/a	n/a
38	CTCF	chr19:53523060-53523210	WI-38	lung:	n/a	n/a
39	CTCF	chr19:53523100-53523250	GM12866	blood:	n/a	n/a
40	CTCF	chr19:53523100-53523250	HCT-116	colon:	n/a	n/a
41	CTCF	chr19:53522860-53523010	K562	blood:	n/a	n/a
42	CTCF	chr19:53522895-53523274	H1-hESC	embryonic stem cell:	n/a	n/a
43	CTCF	chr19:53513900-53514050	HepG2	liver:	n/a	n/a
44	CTCF	chr19:53522940-53523090	HCT-116	colon:	n/a	n/a
45	CTCF	chr19:53523481-53523551	Kidney_OC	kidney:	n/a	n/a
46	CTCF	chr19:53523100-53523250	HCM	heart:	n/a	n/a
47	CTCF	chr19:53523060-53523210	HL-60	blood:	n/a	n/a
48	CTCF	chr19:53532720-53532870	HCFaa	heart:	n/a	n/a
49	CTCF	chr19:53523155-53523182	HepG2	liver:	n/a	n/a
50	CTCF	chr19:53523040-53523190	GM12872	blood:	n/a	n/a

(count:491 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:53540902-53540952	NT2-D1	testis:	n/a
2	chr19:53559508-53559558	HRE	kidney:	n/a
3	chr19:53541186-53541236	AoSMC	blood vessel:	n/a
4	chr19:53540902-53540952	NT2-D1	testis:	n/a
5	chr19:53559508-53559558	HRE	kidney:	n/a
6	chr19:53541186-53541236	AoSMC	blood vessel:	n/a
7	chr19:53540902-53540952	NHDF-neo	bronchial:	n/a
8	chr19:53540845-53540895	GM12878	blood:	n/a
9	chr19:53557328-53557378	SK-N-SH_RA	brain:	n/a
10	chr19:53559508-53559558	HRCEpiC	kidney:	n/a
11	chr19:53538883-53538933	HCPEpiC	choroid plexus:	n/a
12	chr19:53540902-53540952	T-47D	breast:	n/a
13	chr19:53540845-53540895	MCF-7	breast:	n/a
14	chr19:53541287-53541337	HAEpiC	amniotic membrane:	n/a
15	chr19:53541186-53541236	AG09319	gingival:	n/a
16	chr19:53559508-53559558	NH-A	brain:	n/a
17	chr19:53541186-53541236	HCPEpiC	choroid plexus:	n/a
18	chr19:53559508-53559558	AG09309	skin:	n/a
19	chr19:53557328-53557378	Caco-2	colon:	n/a
20	chr19:53540845-53540895	HepG2	liver:	n/a
21	chr19:53540845-53540895	HRPEpiC	eye:	n/a
22	chr19:53557328-53557378	K562	blood:	n/a
23	chr19:53559508-53559558	HEK293	kidney:	embryo
24	chr19:53540902-53540952	IMR90	lung:	fetal
25	chr19:53541287-53541337	AG04450	lung:	fetal
26	chr19:53538687-53538737	HNPCEpiC	eye:	n/a
27	chr19:53541186-53541236	SK-N-MC	brain:	n/a
28	chr19:53538883-53538933	A549	lung:	n/a
29	chr19:53557328-53557378	HL-60	blood:	n/a
30	chr19:53541186-53541236	BJ	skin:	n/a
31	chr19:53557328-53557378	AG09309	skin:	n/a
32	chr19:53540845-53540895	HEEpiC	esophagus:	n/a
33	chr19:53540902-53540952	BJ	skin:	n/a
34	chr19:53538883-53538933	NHDF-neo	bronchial:	n/a
35	chr19:53557328-53557378	Hela-S3	cervix:	n/a
36	chr19:53541287-53541337	A549	lung:	n/a
37	chr19:53540845-53540895	HEK293	kidney:	embryo
38	chr19:53540902-53540952	HCF	heart:	n/a
39	chr19:53538883-53538933	LNCaP	prostate:	n/a
40	chr19:53540845-53540895	U87	brain:	n/a
41	chr19:53540902-53540952	HIPEpiC	eye:	n/a
42	chr19:53559508-53559558	PrEC	prostate:	n/a
43	chr19:53540902-53540952	K562	blood:	n/a
44	chr19:53559508-53559558	BJ	skin:	n/a
45	chr19:53559508-53559558	NB4	blood:	n/a
46	chr19:53538687-53538737	HEEpiC	esophagus:	n/a
47	chr19:53541287-53541337	HUVEC	blood vessel:	n/a
48	chr19:53540845-53540895	HNPCEpiC	eye:	n/a
49	chr19:53541287-53541337	MCF-7	breast:	n/a
50	chr19:53541186-53541236	MCF10A-Er-Src	breast:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:9353360..9353955-chr19:53525559..53526530,2	MCF-7	breast:
2	chr19:53541069..53542606-chr19:53543581..53546044,2	K562	blood:
3	chr19:53536567..53539141-chr19:53540653..53542425,2	K562	blood:
4	chr19:53515874..53517968-chr19:53519511..53521544,2	K562	blood:
5	chr19:53237008..53239147-chr19:53540786..53542527,2	MCF-7	breast:
6	chr19:53514929..53517284-chr19:53527300..53529548,2	MCF-7	breast:
7	chr19:53557284..53559670-chr19:53575484..53577211,2	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZNF816-2	chr19:53540978-53541136	NONHSAT067613
2	lnc-ZNF160-1	chr19:53517843-53519833	ENSG00000251255
3	lnc-ZNF160-1	chr19:53517584-53517806	ENSG00000251255

No data

Variant related genes	Relation type
ERVV-1	TF binding region
ERVV-2	TF binding region
ZNF702P	TF binding region
ERVV-1	CpG island
ERVV-2	CpG island
ZNF702P	CpG island
ENSG00000213020	chromatin interactions
ENSG00000242779	chromatin interactions
ENSG00000269526	chromatin interactions
RNF4	miRNA target sites
GPR107	miRNA target sites

Extended variants
information (count: 1842 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:1842 , 50 per page) page: 1 2 3 4 5 6 7 ... 37

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs78455496	chr19:53511377-53511378	Flanking Active TSS ZNF genes & repeats Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs528488920	chr19:53511405-53511406	Flanking Active TSS ZNF genes & repeats Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs546686439	chr19:53511418-53511419	Flanking Active TSS ZNF genes & repeats Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs571444610	chr19:53511475-53511476	Flanking Active TSS ZNF genes & repeats Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs566548341	chr19:53511476-53511477	Flanking Active TSS ZNF genes & repeats Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs557174256	chr19:53511478-53511479	Flanking Active TSS ZNF genes & repeats Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs577110229	chr19:53511504-53511505	Flanking Active TSS ZNF genes & repeats Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs550386809	chr19:53511505-53511506	Flanking Active TSS ZNF genes & repeats Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs188392523	chr19:53511549-53511550	Flanking Active TSS ZNF genes & repeats Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs536124719	chr19:53511567-53511568	Flanking Active TSS ZNF genes & repeats Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs554860902	chr19:53511570-53511571	Flanking Active TSS ZNF genes & repeats Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs539610742	chr19:53511582-53511583	Flanking Active TSS ZNF genes & repeats Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs533823008	chr19:53511608-53511609	Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs558677146	chr19:53511636-53511637	Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs577046940	chr19:53511669-53511670	Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs545597232	chr19:53511673-53511674	Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs552175065	chr19:53511690-53511691	Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs142768909	chr19:53511708-53511709	Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs575802587	chr19:53511718-53511719	Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs542904307	chr19:53511727-53511728	Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs561671423	chr19:53511732-53511733	Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs190151480	chr19:53511733-53511734	Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs570144522	chr19:53511792-53511793	Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs140128698	chr19:53511809-53511810	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs150060287	chr19:53511843-53511844	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs532439650	chr19:53511862-53511863	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs115177390	chr19:53511867-53511868	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs182460022	chr19:53511880-53511881	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs376175111	chr19:53511911-53511912	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs548187081	chr19:53511934-53511935	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs569662750	chr19:53511935-53511936	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs566798270	chr19:53511949-53511950	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs552925482	chr19:53511953-53511954	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs533755634	chr19:53511964-53511965	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs145407983	chr19:53512001-53512002	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs368620251	chr19:53512003-53512004	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs537470885	chr19:53512012-53512013	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs537898503	chr19:53512094-53512095	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs1617479	chr19:53512120-53512121	Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs575745675	chr19:53512228-53512229	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs148705712	chr19:53512237-53512238	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs186831756	chr19:53512254-53512255	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs573226879	chr19:53512300-53512301	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs540544482	chr19:53512360-53512361	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs142279431	chr19:53512389-53512390	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs576837385	chr19:53512412-53512413	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs544335108	chr19:53512422-53512423	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs535157569	chr19:53512427-53512428	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs376500202	chr19:53512451-53512452	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs563047983	chr19:53512474-53512475	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Colorectal cancer	16272173	CNVD
Ovarian cancer	21781307	CNVD
Neuroblastoma	20406844	CNVD
Melanoma	17363583	CNVD
Breast cancer	21785460	CNVD
Adrenocortical carcinoma	18281524	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:253 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:53508000-53513200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr19:53510400-53511400	Flanking Active TSS	Placenta	Placenta
3	chr19:53510600-53511600	ZNF genes & repeats	H9 Derived Neuron Cultured Cells	ES cell derived
4	chr19:53511000-53511800	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr19:53511200-53511400	Enhancers	Right Ventricle	heart
6	chr19:53511200-53511800	Bivalent Enhancer	K562	blood
7	chr19:53511200-53512600	Enhancers	Placenta Amnion	Placenta Amnion
8	chr19:53511400-53511800	Active TSS	Placenta	Placenta
9	chr19:53511400-53512000	Weak transcription	Right Ventricle	heart
10	chr19:53511600-53512200	Enhancers	Skeletal Muscle Male	skeletal muscle
11	chr19:53511800-53512000	Flanking Active TSS	Placenta	Placenta
12	chr19:53511800-53512400	Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
13	chr19:53512000-53512200	Active TSS	Placenta	Placenta
14	chr19:53512200-53512400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
15	chr19:53512200-53512400	Flanking Active TSS	Placenta	Placenta
16	chr19:53512200-53512400	Enhancers	Right Ventricle	heart
17	chr19:53512400-53512600	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
18	chr19:53512400-53513000	Enhancers	Placenta	Placenta
19	chr19:53512400-53513200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
20	chr19:53512400-53513400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
21	chr19:53512600-53514200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
22	chr19:53512600-53518800	Weak transcription	Placenta Amnion	Placenta Amnion
23	chr19:53513000-53513800	Genic enhancers	Placenta	Placenta
24	chr19:53513200-53513400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr19:53513200-53513600	Enhancers	iPS-15b Cell Line	embryonic stem cell
26	chr19:53513400-53514000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr19:53513400-53514200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
28	chr19:53513600-53513800	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
29	chr19:53513800-53514000	Flanking Active TSS	Placenta	Placenta
30	chr19:53513800-53514200	Enhancers	iPS-15b Cell Line	embryonic stem cell
31	chr19:53514000-53514200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr19:53514000-53516600	Enhancers	Placenta	Placenta
33	chr19:53514200-53518800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
34	chr19:53516600-53517200	Genic enhancers	Placenta	Placenta
35	chr19:53517200-53518600	Weak transcription	Placenta	Placenta
36	chr19:53518600-53519400	ZNF genes & repeats	Foreskin Fibroblast Primary Cells skin01	Skin
37	chr19:53518600-53519400	Genic enhancers	Placenta	Placenta
38	chr19:53518800-53519200	Genic enhancers	Placenta Amnion	Placenta Amnion
39	chr19:53518800-53519400	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
40	chr19:53519200-53519400	Enhancers	Placenta Amnion	Placenta Amnion
41	chr19:53519400-53519800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
42	chr19:53519400-53520400	Weak transcription	Placenta Amnion	Placenta Amnion
43	chr19:53519400-53520600	Enhancers	Placenta	Placenta
44	chr19:53519800-53520200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr19:53520400-53520600	Enhancers	Placenta Amnion	Placenta Amnion
46	chr19:53520400-53520800	Enhancers	Osteobl	bone
47	chr19:53522600-53523400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
48	chr19:53527800-53528000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr19:53528000-53538600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr19:53529400-53530000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links